Viewing Study NCT03603886



Ignite Creation Date: 2024-05-06 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 12:50 PM
Study NCT ID: NCT03603886
Status: COMPLETED
Last Update Posted: 2020-11-04
First Post: 2018-07-11

Brief Title: Adolescent Cancer Telemedicine for Pain Management
Sponsor: University of California Los Angeles
Organization: University of California Los Angeles

Study Overview

Official Title: Telemedicine Pain Control Program for Teens Undergoing Treatment for Cancer
Status: COMPLETED
Status Verified Date: 2020-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Pain in adolescents undergoing treatment for cancer is a common problem often related to treatment or to the cancer itself Due to increasing outpatient-based cancer treatment the burden of care and pain management has shifted to the home environment Yet there are limited interventions that target the management of pain at home Adolescence is marked by increased need for independence and social integration both of which can be impaired by pain or fear of pain To address unique needs during this developmental period this study will test a telemedicine program to enhance pain knowledge and pain control strategies in adolescents ages 12-21 years who are undergoing treatment for cancer

Fifty-six teens will be randomized to an intervention or wait-list control condition Patients randomized to the waitlist control condition will receive the intervention following completion of the waitlist condition The intervention will consist of four weekly 30-45 minute telemedicine online via videoconferencing platform sessions with a trained social work or psychology provider Sessions will focus on pain psychoeducation coping tools communication and stress management Participants will complete online questionnaires assessing pain coping pain management and pain-related impairment at pre-intervention post-intervention and 1- and 2-month follow-up
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None